CK Life Sciences International Holdings Inc

00775

Company Profile

  • Business description

    CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.

  • Contact

    2 Dai Fu Street
    Tai Po Industrial Estate
    Tai Po
    Hong Kong
    HKG

    T: +852 21261212

    https://www.ck-lifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    1,920

Stocks News & Analysis

stocks

Nvidia earns upgrade as AI buildouts accelerate

Demand for AI infrastructure shows no signs of slowing.
stocks

ASX supermarket share outperforms

Supermarket turnaround drives earnings higher.
stocks

Weekly earnings wrap: FMG, WDS, COL and more

A closer look at the final major results from August reporting season.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,294.3032.900.36%
CAC 408,399.9680.090.96%
DAX 4026,499.20131.960.50%
Dow JONES (US)53,569.44105.560.20%
FTSE 10010,810.2217.680.16%
HKSE25,584.7919.050.07%
NASDAQ26,541.35411.151.57%
Nikkei 22566,405.56273.590.41%
NZX 50 Index13,768.18111.87-0.81%
S&P 5007,730.9955.290.72%
S&P/ASX 2009,092.3041.000.45%
SSE Composite Index3,952.184.39-0.11%

Market Movers